U.S. Department of Health and Human Services Unveils AI in Healthcare Strategy for 2025

3月 17, 2025

In early 2025, the U.S. Department of Health and Human Services (HHS) released a nearly 200-page “AI in Healthcare Strategic Plan”, outlining how the U.S. government intends to accelerate the adoption of AI in the healthcare sector. The plan focuses on four key goals: fostering innovation and application of AI in healthcare, promoting trustworthy AI development, ensuring ethical AI use, and protecting patients. This strategy not only highlights the U.S. government’s recognition of AI’s potential in healthcare but also signals a new wave of transformation in the global AI healthcare market.

Reshaping Healthcare with New Technology

In the HHS strategy, AI in healthcare is not an isolated concept but one that integrates into the entire healthcare ecosystem. The last concept of similar importance was “digital health” a decade ago. As we know, “digital health” drove the industry’s digital transformation, creating a vast and dynamic market and giving rise to many successful companies. Clearly, HHS has high expectations for AI in healthcare. Beyond the belief in AI’s potential, the enthusiasm of markets and investors likely spurred HHS to prioritize AI in healthcare:

The HHS AI strategy is divided into five core areas and two supplementary domains. Each core area aims to achieve the four key goals mentioned above. By breaking these goals into specific tasks and assigning responsibilities, HHS has created a comprehensive action plan to drive AI adoption in healthcare.

 

Deep Dive into the Healthcare Services Domain

Among the five core areas, healthcare services stand out as a critical and controversial sector, especially in the U.S. Feedback collected by HHS reveals that some healthcare providers, including hospitals, clinics, and doctors, remain cautious about AI’s clinical applications, contrary to the expected rapid embrace of new technology.

Their concerns stem from distrust in AI, as described in the strategic plan:

 

 

Predictions for AI Trends in U.S. Healthcare

  1. Massive and Growing Investments in AI Healthcare

   AI healthcare projects account for about 25% of all healthcare venture capital investments, totaling over $19 billion since 2021, with $7 billion in 2023 alone. Preliminary reports show that two-thirds of these investments target clinical applications, while the remaining third focuses on administrative uses.

 

  1. Enthusiasm and Concerns Coexist

   A survey of 100 healthcare leaders found that over 70% have already or plan to deploy AI in healthcare. However, another survey revealed that about 40% of doctors are excited but also worried. They fear AI could reshape employment in healthcare and potentially harm doctor-patient relationships. In 2022, 60% of patients expressed discomfort with doctors relying on AI.

 

  1. Heterogeneity in Data and IT Systems

   Differences in data management, clinical and administrative systems, and infrastructure (e.g., cloud computing) hinder AI adoption. Variations in data formats and standards across institutions further complicate cross-institutional AI applications, influencing decision-makers’ choices in AI strategies and partnerships.

 

  1. Increased Innovation in Administrative AI

   In recent years, AI has made strides in administrative tasks due to lower development costs compared to clinical use cases and advancements in GenAI and LLM technologies. Recent applications include extracting medication names from doctors’ notes, answering patient queries, summarizing medical conversations, and drafting medical histories. According to the American Medical Association, 54% of doctors are excited about using AI for administrative tasks like documentation.

 

Despite its promising future, AI in healthcare faces significant challenges. Data privacy and security remain major barriers. The lack of transparency and explainability in AI models undermines trust among doctors and patients. Additionally, data silos across institutions limit AI’s effectiveness.

Clearly, the challenges faced by the U.S. in integrating AI into clinical work mirror those in other countries. International collaboration, data sharing, and improving AI transparency can help foster the healthy development of AI in healthcare.

 

讯升

At Comrise, we offer tailored solutions for the full-time, part-time, direct-hire, contract, and permanent talent that your business needs. For 40 years, we have delighted our clients and candidates by focusing on customer satisfaction, innovation, and flexible workforce solutions!

If you’re looking for new job opportunities click here, or if you’re looking for a reliable partner to help you secure top-notch candidates for hard-to-fill roles, click here. For more information, feel free to contact us, click here.

相关文章

US Job Market Grows in February Amid Shifts in Temporary Employment

4月 25, 2025

The US labor market recorded a gain of 151,000 jobs in February, highlighting continued momentum in overall employment, according to data released by the Bureau of Labor Statistics (BLS) on...

UK Ranks Among Europe’s Most Attractive Markets for Battery Energy Storage (BESS) Investment

4月 21, 2025

The UK’s 2023 Energy Security Bill pledged £1.6 billion for energy storage, focusing on long-duration storage (LDES) R&D. The government aims to match clean energy production with consumption by 2030....

China's Chip Industry Shifts from Followers to Innovators

4月 14, 2025

Amid the global semiconductor industry’s push toward smarter technology, Chinese chip firms are transforming from followers into innovators. Breakthroughs in heterogeneous computing, advanced manufacturing, and Chiplet packaging are reshaping the...

全球联系信息

我们在全球各地都有办事处。请确保您与您所在地区的正确办公室取得联系。

United States

Woodbridge, NJ (全球总部)

90 Woodbridge Center Drive Suite 360
Woodbridge, NJ 07095

Tel: 1-732-739-2330
Fax: 1-732-739-1996

Philippines

Metro Manila

1105 Raffles Corporate Center, Ortigas Center, Pasig City, Metro Manila, Philippines

Malaysia

Kuala Lumpur

Unit B12, Level 1, Menara BT, Tower 3, Avenue 7,
Horizon Phase 2, Bangsar South, No.8, Jalan Kerinchi, 59200 Kuala Lumpur, Malaysia

Tel: +60-03-27794130

 

中国

北京

Room 1015, 10/F, Hanweidasha Building, Guanghualu Road, Chaoyang District, Beijing,100020

Tel: +86 10 58780578

北京市朝阳区光华路7号汉威大厦东区1015室

邮编:100020
电话:+86 10 58780578

青岛

15A, 22nd Century Mansion, 39 Longcheng Road, Shibei District, Qingdao ,China

青岛市市北区龙城路39号二十二世纪大厦15a

上海

Room 18F/G/H, Shanghai Industrial Investment Building, No.18 Caoxi Road, Xuhui District, Shanghai, 200030

电话:+86 21 64270570

上海市徐汇区漕溪北路18号上海实业大厦18楼F/G/H座

邮编:200030
电话:+86 21 64270570

成都

26th Floor Bldg.2,No.88 Jitai 5th Road, Xiangnian Square, Tianfu Avenue, Hi-Tech Zone, Chengdu, Sichuan, 610041

Tel: +86 28 86703369

四川省成都市高新区天府大道中段吉泰五路88号香年广场T2座26层

邮编:610041
电话:+86 28 86703369

香港

EA Licence no. 66051 & 64845

5/F Heng Shan Centre, 145 Queen’s Road East, Wan Chai, Hong Kong

Tel: +852 36223225

牌照号码: 66051 & 64845

香港湾仔皇后大道东145号恒山中心5楼

电话:+852 36223225

Wuhan

Room 1419, 14 / F, Building A, New World Center, No. 634, Jiefang Street, Qiaokou District, Wuhan, Hubei

Xi’an

C17, 18 / F, Block E, Chang’an International Center, 88 Nanguanzheng street, Xi’an, Shaanxi

Hefei

A11-10, 1701, Building 7, Wanda Office Building, Wuhu Road, Hefei, Anhui

改变语言